Journal article
Idiopathic pulmonary fibrosis and a role for autoimmunity
Immunology & Cell Biology, Vol.95(7), pp.577-583
2017
Abstract
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It is typically associated with extensive and progressive fibrosis, and is fatal and has limited treatment options. Characteristically IPF patients display large lymphocyte aggregates composed of CD3+ T cells and CD20+ B cells within the lung tissue that are located near sites of active fibrosis. In addition, IPF patients can have autoantibodies to a range of host antigens, suggesting a breakdown in immunological tolerance. In this review, we examine the role of T and B cells in IPF pathogenesis and discuss how loss of self-tolerance to lung-specific proteins could exacerbate disease progression in IPF. We discuss what these results mean in terms of future prospects for immunotherapy of IPF.
Details
- Title
- Idiopathic pulmonary fibrosis and a role for autoimmunity
- Authors/Creators
- G.F. Hoyne (Author/Creator)H. Elliott (Author/Creator)S.E. Mutsaers (Author/Creator)C.M. Prêle (Author/Creator)
- Publication Details
- Immunology & Cell Biology, Vol.95(7), pp.577-583
- Publisher
- Wiley
- Identifiers
- 991005544745107891
- Copyright
- © 2017 Australasian Society for Immunology Inc.
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
24 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.208 Vasculitis & Autoimmune Disorders
- 1.208.1262 Idiopathic Pulmonary Fibrosis
- Web Of Science research areas
- Cell Biology
- Immunology
- ESI research areas
- Immunology